January 12, 2023

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 12, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2023 , to stockholders of record as
<span>Labcorp opens new Los Angeles based laboratory</span>
December 8, 2022

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in
August 11, 2022

BD, Labcorp collaborate to develop flow cytometry-based companion diagnostics for matching patients with treatments

FRANKLIN LAKES, N.J., August 9, 2022 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp (NYSE: LH), a leading global life sciences company, creating a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases.
July 12, 2022

Redi.Health collaborates with Labcorp to seamlessly connect patients and providers

COLUMBUS, O.H., July 12, 2022 — Today, Redi.Health, provider of health management technology that improves total patient health, is announcing a collaboration with Labcorp, a leading global life sciences company. Through this combined effort, Labcorp Drug Development’s Patient Access Solutions will integrate Redi.Health’s digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.
<span>Circuit Clinical and Pottstown Medical Specialists (PMSI) bring clinical research to 180K+ patients across greater northwest Philadelphia region</span>
June 28, 2022

Circuit Clinical and Pottstown Medical Specialists (PMSI) bring clinical research to 180K+ patients across greater northwest Philadelphia region

BUFFALO, N.Y., June 28, 2022 — Following its mission to transform the way patients find, choose, and experience clinical research, Circuit Clinical - one of the nation's fastest-growing research networks - has partnered with Pottstown Medical Specialists (PMSI) - a leading primary care and specialty services physician network - to bring clinical research as a care option close to home for over 180,000 residents across the area's Montgomery and Berks counties. Clinical trial opportunities will be provided by Labcorp, a global life sciences company.
May 26, 2022

Labcorp signs statement of support for guard and reserve members

BURLINGTON, N.C., May 26, 2022 — North Carolina Employer Support of the Guard and Reserve (ESGR), a United States Department of Defense program, announced today that Labcorp, a global life sciences company, signed a Statement of Support for the Guard and Reserve at its corporate headquarters in Burlington, N.C. Representatives of Labcorp’s Veteran Employee Resource Group (VERG) and others attended this event in person and virtually.
May 24, 2022

Walgreens expands access to COVID-19 testing services by offering Pixel by Labcorp® At-Home COVID-19 PCR Kits at no cost through curbside and in-store pickup

DEERFIELD, Ill., May 23, 2022 — Walgreens, in collaboration with the U.S. Department of Health and Human Services (HHS) and Labcorp, a leading global life sciences company, today announced a program to make Pixel by Labcorp®[1] COVID-19 at-home PCR collection kits available for curbside and in-store pickup at more than 1,000 stores nationwide. This program is designed to offer customers access to convenient, reliable testing at no cost and with no insurance or eligibility requirements.  This initiative builds on Walgreens collaboration with HHS and Labcorp to offer COVID-19 at-home collection kits nationwide at no cost to individuals who meet clinical guidelines.[2]